Pharm cards 1 Flashcards
(226 cards)
cladribine
mech:
pruine analog -> multiple mechs (eg inhbition of dna polymerase, dna strand breaks)
hairy cell leukemia
myelosupression
nephrotxic
neurotoxcity
dactinomycin (actinomycin d)
antitumor
intercalates dna
inhibits rna polymerase
wilms tumor, ewing sarcoma, rhabdomyosarcoma, used for childhood tumors.
myelosupression
bevacizumab
mab agaisnt vegf, inhbiting angiogenesis.
solid tumors (colon renal cell carcinoma)
hemmorhage, blood clots, and impaired wood healing
rituximab
monoclonal antibody against cd20. found on most b cell neoplasms
non hodgkin lymphoma, cll, itp, RA
increased risk of PML
Vemurafenib
small molecule inhbitor of BRAF oncogene in + melanomas. for v600e mutation.
metastatic melanoma
tumor lysis syndrome
emergency, most often in treatment of leukemias/lymphomas.
hyperkalemia and hyperphosphatemia, increased phosphate causes decreased calcium. increased nucelec acid breakdown -> hyperuricemia -> AKI
treat with agressive hydration, allopurinol, rasburicase.
rasburicase
recombinant uricase -> uric acid to allantoid
use in prevention and treatment of tumor lysis syndrome
idarucizumab
mab against dabigatran
tranexamic acid
inhibits fibrin breakdown
alemtuzumab
mab to cd52
cll and ms
daclizumab
cd25 (part of il2 receptor)
relapsing MS
natalizumab
a4 integrin (involved in WBC adhesion)
MS and chron disease
Risk of PML in patients with JC virus
ustekinumab
il-12/il-23
psorisasis, psoriatic arthritis
ranibizumab, bevacizumab
vegf
neovascular age related macular degeneration, proliferative diabetic retinopathy, and macular edema
alirocumab
pcsk9 inhibitor
decrease decrease decrease / increase / decrease
inactivated ldl receptor degradation, increased ldl removed from blood
myalagias, delirium, dementia, other neurocognitive defects
evolucumab
pcsk9 inhibitor
decrease decrease decrease / increase / decrease
inactivated ldl receptor degradation, increased ldl removed from blood
myalagias, delirium, dementia, other neurocognitive defects
ivabradine
antiarrythymic
selective inhibition of funny na channels. prolongs phase 4. decreases sa node firing. negative chronotrope without inotrope. reduces o2 requirement.
chronic stable angina in people who cant take b blockers. chronic HF with reduced ejection fraction.
luminous phenomana/visual brightness, hypertension, bradycardia
cefazolin
1st cephalo
cephalexin
1st cephalo
cefaclor
2nd cepha
cefoxitin
2nd cepha
cefuroxime
2nd cepha
ceftriaxone
3rd cepha
cefotaxime
3rd cepha